Back to search

Article

The Economics of Profit-Cap Policy: Big Pharma, Big Tech, and the Duopoly Rule

2023-02-03

Abstract excerpt

A known policy dilemma occurs between the need to curb extra-large profits by some industries, like pharmaceuticals, and the need to ensure the incentive to produce is not damaged. This paper shows that a profit cap, imposed via taxation on a group of firms, can simultaneously eliminate inefficiency and excess profit by intensifying competition among oligopolistic firms. The result has a direct bearing on policy d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1bff7b28-e4ef-5254-8bfd-365dc484f09b
DOI
10.2139/ssrn.4228280
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Economics of Profit-Cap Policy: Big Pharma, Big Tech, and the Duopoly RuleDOI 10.2139/ssrn.4228280
Select a neighboring publication to make it the new centre.